Solid Biosciences LLC
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -395 | -467 | -376 | |
EBITDA | -54,013 | -56,342 | -49,320 | -45,400 |
EBIT | -54,799 | -56,737 | -49,787 | -45,776 |
Net Income | -54,799 | -56,737 | -49,787 | -45,776 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -52,737 | -47,395 | -54,120 | -33,557 |
Cash | 159,394 | 297,737 | 59,900 | 61,364 |
Basic Shares | 143,688 | 109,811 | 94,731 | 94,417 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $8,094 |
Gross Profit | -1,636 | -2,455 | -2,581 | 8,094 |
EBITDA | -172,689 | -121,902 | -93,434 | -96,866 |
EBIT | -174,325 | -124,357 | -96,015 | -99,274 |
Net Income | -174,325 | -124,697 | -96,015 | -85,981 |
Net Change In Cash | 0 | 0 | 0 | 8,094 |
Cost of Revenue | 36,011 | |||
Free Cash Flow | -157,442 | -100,666 | -95,695 | -100,992 |
Cash | 59,900 | 80,235 | 74,015 | 155,384 |
Basic Shares | 87,504 | 40,817 | 19,884 | 8,512 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.38 |
2026-03-31 | -$0.51 |
2025-12-31 | -$0.53 |
2025-09-30 | -$0.48 |